
Khiron Life Sciences Corp. (OTCQX:KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC) released its financial results for the quarter ended March 31, 2022, revealing record revenue in the medical cannabis business.

Khiron Life Sciences Corp. (OTCQX:KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC) released its financial results for the quarter ended March 31, 2022, revealing record revenue in the medical cannabis business.